AMAG Pharmaceuticals ROIC
Quel est le ROIC de AMAG Pharmaceuticals?
Le ROIC de AMAG Pharmaceuticals, Inc. est -44.83%
Quelle est la définition de ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC des entreprises dans Health Care secteur sur NASDAQ par rapport à AMAG Pharmaceuticals
Que fait AMAG Pharmaceuticals?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Entreprises avec roic similaire à AMAG Pharmaceuticals
- Rhino Resource Partners LP a ROIC de -45.00%
- Kaili Resources a ROIC de -45.00%
- Colossus Resources Corp a ROIC de -45.00%
- General Assembly a ROIC de -44.94%
- Minco Capital a ROIC de -44.85%
- Allogene Therapeutics Inc a ROIC de -44.83%
- AMAG Pharmaceuticals a ROIC de -44.83%
- Actual Experience plc a ROIC de -44.80%
- Scancell Plc a ROIC de -44.80%
- Emcore a ROIC de -44.79%
- Sensyne Health plc a ROIC de -44.72%
- Outset Medical a ROIC de -44.71%
- Extraction Oil & Gas a ROIC de -44.71%